Effectiveness of baricitinib and tofacitinib compared with bDMARDs in RA: results from a cohort study using nationwide Swedish register data

OBJECTIVES: To describe the use of baricitinib and tofacitinib by Swedish RA patients and to compare their effectiveness with that of biologic DMARDs (bDMARDs). METHODS: RA patients who initiated baricitinib (n = 1420), tofacitinib (n = 316), abatacept (n = 1050), IL-6 inhibitors (IL-6is; n = 849),...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbulescu, Andrei, Askling, Johan, Chatzidionysiou, Katerina, Forsblad-d’Elia, Helena, Kastbom, Alf, Lindström, Ulf, Turesson, Carl, Frisell, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536798/
https://www.ncbi.nlm.nih.gov/pubmed/35134119
http://dx.doi.org/10.1093/rheumatology/keac068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536798/
https://www.ncbi.nlm.nih.gov/pubmed/35134119
http://dx.doi.org/10.1093/rheumatology/keac068

Ejemplares similares